Efficacy of IFN therapy based on duration period of negative HCV-RNA during IFN administration

Hepatology Research

Volumn 19, Issue 1, 2001, Pages 22-30

  Arase, Yasuji ^a   Ikeda, Kenji ^a   Chayama, Kazuaki ^a   Murashima, Naoya ^a   Tsubota, Akihito ^a   Suzuki, Yoshiyuki ^a   Saitoh, Satoshi ^a   Kobayashi, Masahiro ^a   Kobayashi, Mariko ^a   Suzuki, Fumitaka ^a   Kumada, Hiromitsu ^a  

^a TORANOMON HOSPITAL   (Japan)

Author keywords

Chronic hepatitis C; HCV RNA; Prolonged interferon therapy

Indexed keywords

ALANINE AMINOTRANSFERASE; ALPHA INTERFERON; ASPARTATE AMINOTRANSFERASE; LYMPHOBLAST INTERFERON; VIRUS RNA;

ADULT; AGED; APPETITE DISORDER; ARTICLE; CONTROLLED STUDY; DEPRESSION; DRUG EFFICACY; DRUG RESPONSE; FATIGUE; FEMALE; GENOTYPE; HEADACHE; HEPATITIS C; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MYALGIA; PRIORITY JOURNAL; RETROSPECTIVE STUDY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VIRUS DETECTION; VIRUS LOAD; VIRUS TYPING;

EID: 0035192173     PISSN: 13866346     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1386-6346(00)00084-X     Document Type: Article

References (25)

1. Disease progression and hepatocellular carcinogenesis in patients with chronic viral hepatitis: A prospective observation of 2215 patients
2. Clinical outcome after transfusion-associated hepatitis C virus infection
3. Hepatitis C virus as a risk factor for hepatocellular carcinoma in patients with cirrhosis. A case control study
4. Factors predictive of response interferon-alpha therapy in hepatitis C virus infection
5. Detection of hepatitis C virus by polymerase chain reaction and response to interferon-α therapy: Relationship to genotypes of hepatitis C virus
6. Detection of hepatitis C virus RNA in serum of patients with chronic hepatitis C treated with interferon-α
7. Recombinant interferon alpha therapy for chronic hepatitis C: A randomized, double blind placebo-controlled trial
8. Comparison of 1 or 3 MU of interferon alfa-2b and placebo in patients with chronic non-A non-B hepatitis
9. Effect of interferon administration on serum hepatitis C virus RNA in patients with chronic hepatitis C
10. Two-year biochemical, virological and histological follow-up in patients with chronic hepatitis C responding in a sustained fashion to interferon alfa-2b treatment
11. Randomized controlled trial of lymphoblastoid interferon α for chronic hepatitis C
12. Ability of prolonged interferon treatment to suppress relapse after cessation of therapy in patients with chronic hepatitis C: A multicenter randomized controlled trial
13. A comparison of three interferon alfa-2b regimens for the long-term treatment of chronic non-A, non-B hepatitis
14. High sustained response rate and clearance of viremia in chronic hepatitis C after treatment with interferon-α 2b for 60 weeks
15. Prolonged treatment (2 years) with different doses (3 versus 6 MU) of interferon 2b for chronic hepatitis type C
16. Efficacy and changes of the nonstructural 5A GENE by prolonged interferon therapy for patients with hepatitis C virus genotype 1b and a high level of serum HCV-RNA
17. Continuous versus intermittent therapy for chronic hepatitis C with recombinant interferon alpha-2a
18. Quantification of hepatitis C virus by competitive reverse transcription polymerase chain reaction: Increase of the virus in advanced liver disease
19. Classification of chronic hepatitis: Diagnosis, grading and staging
20. Risk factors for hepatocellular carcinoma and its incidence after interferon treatment in patients with chronic hepatitis C
21. Relation of interferon therapy and hepatocellular carcinoma in patients with chronic hepatitis C. Osaka hepatocellular carcinoma prevention study group
22. Interferon therapy lowers the rate of progression to hepatocellular carcinoma in chronic hepatitis C but not significantly in an advanced stage: A retrospective study in 1148 patients. Viral hepatitis therapy study group
23. Typing six major hepatitis C virus genotypes by polymerase chain reaction using primers derived from nucleotide sequences of NS5 region
24. Hepatitis C virus genotypes: An investigation of type-specific differences in genographic origin and disease
25. Investigation of the pattern of hepatitis. C virus sequence diversity in different geographical regions: Implications for virus classification